Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy

Annals of Internal Medicine

Volumn 136, Issue 6, 2002, Pages 449-452

  May, Louis D ^a   Lefkowitch, Jay H ^a   Kram, Michael T ^a   Rubin, David E ^a  

^a Gastrointest Associates of Rockland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; BILIRUBIN; LIVER ENZYME; PIOGLITAZONE;

ABDOMINAL DISCOMFORT; ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLESTATIC HEPATITIS; DISEASE COURSE; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL DAMAGE; LIVER INJURY; MALE; NAUSEA; PRIORITY JOURNAL; TOXIC HEPATITIS;

EID: 0037133507     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-136-6-200203190-00008     Document Type: Article

References (10)

1. The glitazones: Proceed with caution
2. Hepatotoxicity due to troglitazone: Report of two cases and review of adverse events reported to the United States Food and Drug Administration
3. Lessons from the glitazones: A story of drug development
4. Hepatic failure in a patient taking rosiglitazone
5. Hepatocellular injury in a patient receiving rosiglitazone. A case report
6. Hepatocellular injury in a patient receiving pioglitazone
7. The natural history of histologically proved drug induced liver disease
8. Thiazolidinediones and liver toxicity